£2.5M
Future Planet Capital led the round as the med-tech startup prepares for international market launches.
AB
AMLo Biosciences
AMLo Biosciences develops diagnostic tests to identify low-risk early-stage skin cancer.
£2.5MTotal raised
A Newcastle University spin-out developing prognostic tests for the early detection and risk stratification of skin cancer.
Categories
Founders
PL
Penny Lovat
Co-founder
ML
Marie Labus
CEO and Co-founder
JM
Jane Meany
Co-founder